Literature DB >> 28613102

A high-throughput platform for population reformatting and mammalian expression of phage display libraries to enable functional screening as full-length IgG.

Xiaodong Xiao1, Julie A Douthwaite2, Yan Chen1, Ben Kemp2, Sara Kidd2, Jennifer Percival-Alwyn2, Alison Smith2, Kate Goode2, Bonnie Swerdlow3, David Lowe2, Herren Wu1, William F Dall'Acqua1, Partha S Chowdhury1.   

Abstract

Phage display antibody libraries are a rich resource for discovery of potential therapeutic antibodies. Single-chain variable fragment (scFv) libraries are the most common format due to the efficient display of scFv by phage particles and the ease by which soluble scFv antibodies can be expressed for high-throughput screening. Typically, a cascade of screening and triaging activities are performed, beginning with the assessment of large numbers of E. coli-expressed scFv, and progressing through additional assays with individual reformatting of the most promising scFv to full-length IgG. However, use of high-throughput screening of scFv for the discovery of full-length IgG is not ideal because of the differences between these molecules. Furthermore, the reformatting step represents a bottle neck in the process because each antibody has to be handled individually to preserve the unique VH and VL pairing. These problems could be resolved if populations of scFv could be reformatted to full-length IgG before screening without disrupting the variable region pairing. Here, we describe a novel strategy that allows the reformatting of diverse populations of scFv from phage selections to full-length IgG in a batch format. The reformatting process maintains the diversity and variable region pairing with high fidelity, and the resulted IgG pool enables high-throughput expression of IgG in mammalian cells and cell-based functional screening. The improved process led to the discovery of potent candidates that are comparable or better than those obtained by traditional methods. This strategy should also be readily applicable to Fab-based phage libraries. Our approach, Screening in Product Format (SiPF), represents a substantial improvement in the field of antibody discovery using phage display.

Entities:  

Keywords:  Antibody; IgG; Screen in Product Format (SiPF); phage display; scFv

Year:  2017        PMID: 28613102      PMCID: PMC5540111          DOI: 10.1080/19420862.2017.1337617

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  34 in total

1.  Selection of full-length IgGs by tandem display on filamentous phage particles and Escherichia coli fluorescence-activated cell sorting screening.

Authors:  Yariv Mazor; Thomas Van Blarcom; Sean Carroll; George Georgiou
Journal:  FEBS J       Date:  2010-05       Impact factor: 5.542

Review 2.  Phage display derived therapeutic antibodies.

Authors:  Holger Thie; Torsten Meyer; Thomas Schirrmann; Michael Hust; Stefan Dübel
Journal:  Curr Pharm Biotechnol       Date:  2008-12       Impact factor: 2.837

Review 3.  Drugs derived from phage display: from candidate identification to clinical practice.

Authors:  Andrew E Nixon; Daniel J Sexton; Robert C Ladner
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

4.  Screening of phage antibody libraries.

Authors:  J L Harrison; S C Williams; G Winter; A Nissim
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

Review 5.  Prokaryotic expression of antibodies.

Authors:  Mehdi Arbabi-Ghahroudi; Jamshid Tanha; Roger MacKenzie
Journal:  Cancer Metastasis Rev       Date:  2005-12       Impact factor: 9.264

6.  A dual host vector for Fab phage display and expression of native IgG in mammalian cells.

Authors:  Devin Tesar; Isidro Hötzel
Journal:  Protein Eng Des Sel       Date:  2013-09-24       Impact factor: 1.650

7.  Amplification of complex gene libraries by emulsion PCR.

Authors:  Richard Williams; Sergio G Peisajovich; Oliver J Miller; Shlomo Magdassi; Dan S Tawfik; Andrew D Griffiths
Journal:  Nat Methods       Date:  2006-07       Impact factor: 28.547

8.  High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells.

Authors:  Volker Jäger; Konrad Büssow; Andreas Wagner; Susanne Weber; Michael Hust; André Frenzel; Thomas Schirrmann
Journal:  BMC Biotechnol       Date:  2013-06-26       Impact factor: 2.563

Review 9.  The role of phage display in therapeutic antibody discovery.

Authors:  Conrad E Z Chan; Angeline P C Lim; Paul A MacAry; Brendon J Hanson
Journal:  Int Immunol       Date:  2014-08-18       Impact factor: 4.823

10.  Application of phage display to high throughput antibody generation and characterization.

Authors:  Darren J Schofield; Anthony R Pope; Veronica Clementel; Jenny Buckell; Susan Dj Chapple; Kay F Clarke; Jennie S Conquer; Anna M Crofts; Sandra R E Crowther; Michael R Dyson; Gillian Flack; Gareth J Griffin; Yvette Hooks; William J Howat; Anja Kolb-Kokocinski; Susan Kunze; Cecile D Martin; Gareth L Maslen; Joanne N Mitchell; Maureen O'Sullivan; Rajika L Perera; Wendy Roake; S Paul Shadbolt; Karen J Vincent; Anthony Warford; Wendy E Wilson; Jane Xie; Joyce L Young; John McCafferty
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  10 in total

1.  Streamlining the Transition From Yeast Surface Display of Antibody Fragment Immune Libraries to the Production as IgG Format in Mammalian Cells.

Authors:  David Fiebig; Jan P Bogen; Stefania C Carrara; Lukas Deweid; Stefan Zielonka; Julius Grzeschik; Björn Hock; Harald Kolmar
Journal:  Front Bioeng Biotechnol       Date:  2022-05-10

Review 2.  Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy.

Authors:  Joachim Koch; Michael Tesar
Journal:  Transfus Med Hemother       Date:  2017-09-11       Impact factor: 3.747

Review 3.  Toxin Neutralization Using Alternative Binding Proteins.

Authors:  Timothy Patrick Jenkins; Thomas Fryer; Rasmus Ibsen Dehli; Jonas Arnold Jürgensen; Albert Fuglsang-Madsen; Sofie Føns; Andreas Hougaard Laustsen
Journal:  Toxins (Basel)       Date:  2019-01-17       Impact factor: 4.546

Review 4.  Advances in the Production and Batch Reformatting of Phage Antibody Libraries.

Authors:  Rose H Reader; Robert G Workman; Ben C Maddison; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2019-11       Impact factor: 2.695

5.  Golden Gate assembly with a bi-directional promoter (GBid): A simple, scalable method for phage display Fab library creation.

Authors:  Karuppiah Chockalingam; Zeyu Peng; Christine N Vuong; Luc R Berghman; Zhilei Chen
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379

6.  A platform-agnostic, function first-based antibody discovery strategy using plasmid-free mammalian expression of antibodies.

Authors:  Ruijun Zhang; Ponraj Prabakaran; Xiaocong Yu; Brian C Mackness; Ekaterina Boudanova; Joern Hopke; Jose Sancho; Jacqueline Saleh; HyunSuk Cho; Ningning Zhang; Helene Simonds-Mannes; Samuel D Stimple; Dietmar Hoffmann; Anna Park; Partha S Chowdhury; Sambasiva P Rao
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

7.  A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies.

Authors:  Fortunato Ferrara; M Frank Erasmus; Sara D'Angelo; Camila Leal-Lopes; André A Teixeira; Alok Choudhary; William Honnen; David Calianese; Deli Huang; Linghan Peng; James E Voss; David Nemazee; Dennis R Burton; Abraham Pinter; Andrew R M Bradbury
Journal:  Nat Commun       Date:  2022-01-24       Impact factor: 17.694

8.  SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian display.

Authors:  Roy A Ehling; Cédric R Weber; Derek M Mason; Simon Friedensohn; Bastian Wagner; Florian Bieberich; Edo Kapetanovic; Rodrigo Vazquez-Lombardi; Raphaël B Di Roberto; Kai-Lin Hong; Camille Wagner; Michele Pataia; Max D Overath; Daniel J Sheward; Ben Murrell; Alexander Yermanos; Andreas P Cuny; Miodrag Savic; Fabian Rudolf; Sai T Reddy
Journal:  Cell Rep       Date:  2021-12-22       Impact factor: 9.423

9.  Recombinant human B cell repertoires enable screening for rare, specific, and natively paired antibodies.

Authors:  Saravanan Rajan; Michael R Kierny; Andrew Mercer; Jincheng Wu; Andrey Tovchigrechko; Herren Wu; William F Dall Acqua; Xiaodong Xiao; Partha S Chowdhury
Journal:  Commun Biol       Date:  2018-01-22

10.  Intein mediated high throughput screening for bispecific antibodies.

Authors:  Tim Hofmann; Johannes Schmidt; Elke Ciesielski; Stefan Becker; Thomas Rysiok; Mark Schütte; Lars Toleikis; Harald Kolmar; Achim Doerner
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.